2025 annual financial data
Bionano Genomics 2025 Operating margin
Direct answer
Operating margin was -116.95%.
Operating income was -33,339,000 USD and net income was -26,395,000 USD.
Operating cash flow was -16,345,000 USD.
Get free Bionano Genomics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 28,508,000 USD
- Operating income
- -33,339,000 USD
- Net income
- -26,395,000 USD
- Operating cash flow
- -16,345,000 USD